Smith & Nephew withdraw 185 BHR (Birmingham Hip Resurfacing) implants:
This article was originally published in Clinica
Executive Summary
Smith & Nephew has recalled 185 of its Birmingham Hip Resurfacing system after discovering that the implants had been incorrectly packaged by the subcontractor. The mistake led to different sized acetabular cups being mixed together. S&N said the error was limited to a small number of batches and that several implants have already been recovered in their packaging. The company added that it has warned, or is in the process of warning, all hospitals that have received the implants and are -working closely" with surgeons and patients on the appropriate corrective action. The UK and US regulatory authorities have also been notified about the recall.
You may also be interested in...
Fenty Cleanser Performance Claims Supported, But Influencer Videos Need Disclaimers – NAD
A National Advertising Division review of claims by LVMH-owned Fenty Skin determined makeup- and dirt-removal representations were substantiated by a study and subject questionnaire, but demo videos from paid endorsers must include disclosures about material connections in accordance with FTC guidelines.
Clinical Trial Diversity Requires Sponsors Work With An Assortment Of Patient Advocates, Community Organizations
US FDA oncology officials are concerned that the entities sponsors are consulting in developing and implementing clinical trial diversity plans are not sufficiently diverse themselves and do not represent patients in underserved communities.
Israeli Company Lands De Novo Clearance For Digital Bone Marrow Application
The US FDA has cleared a novel software application to enhance the analysis of bone marrow smears. Using the AI-powered tool, hematopathologists may be able to better diagnose various blood and marrow diseases.